Stock RVV REVIVE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Revive Therapeutics Ltd.

Equities

RVV

CA7615161030

Market Closed - Canadian Securities Exchange
Other stock markets
 01:48:37 2024-05-17 pm EDT 		5-day change 1st Jan Change
0.025 CAD 0.00% Intraday chart for Revive Therapeutics Ltd. -16.67% -16.67%
Apr. 23 FDA Grants Revive Therapeutics Type C Meeting Request For Bucillamine Study to Treat Long COVID MT
Apr. 23 Revive Therapeutics Brief: Announcing Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REVIVE THERAPEUTICS LTD. Stock Revive Therapeutics Ltd.
 7.69M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
ARGENX SE Stock argenx SE
 21.6B -
BIONTECH SE Stock BioNTech SE
 22.31B -
GENMAB A/S Stock Genmab A/S
 19.19B
  1. Stock Market
  2. Equities
  3. RVV Stock
  4. Charts Revive Therapeutics Ltd.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW